LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Open accessAbstract
Ferroptosis has emerged as an attractive strategy in cancer therapy. Understanding the operational networks regulating ferroptosis may unravel vulnerabilities that could be harnessed for therapeutic benefit. Using CRISPR‐activation screens in ferroptosis hypersensitive cells, we identify the selenoprotein P (SELENOP) receptor, LRP8, as a key determinant protecting MYCN ‐amplified neuroblastoma cells from ferroptosis. Genetic deletion of LRP8 leads to ferroptosis as a result of an insufficient supply of selenocysteine, which is required for the translation of the antiferroptotic selenoprotein GPX4. This dependency is caused by low expression of alternative selenium uptake pathways such as system Xc − . The identification of LRP8 as a specific vulnerability of MYCN ‐amplified neuroblastoma cells was confirmed in constitutive and inducible LRP8 knockout orthotopic xenografts. These findings disclose a yet‐unaccounted mechanism of selective ferroptosis induction that might be explored as a therapeutic strategy for high‐risk neuroblastoma and potentially other MYCN ‐amplified entities.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRP8 has been recently shown to affect ferroptosis by regulating the level of selenoprotein GPX4 in cancer cells.
“LRP8 has been recently shown to affect ferroptosis by regulating the level of selenoprotein GPX4 in cancer cells (54–56).”
From Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis (2024) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 48 · Cited by 85
Research works printed but not linked: 39
- Alborzinia H, Florez AF, Kreth S, Bruckner LM, Yildiz U, Gartlgruber M, Odoni DI, Poschet G, Garbowicz K, Shao C et al (2022) MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. Nat Cancer 3: 471– 485 35484422 PMC9050595
- Basu A, Bodycombe NE, Cheah JH, Price EV, Liu K, Schaefer GI, Ebright RY, Stewart ML, Ito D, Wang S et al (2013) An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 154: 1151– 1161 23993102 PMC3954635
- Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575: 688– 692 31634900 PMC6883167
- Brutsch SH, Wang CC, Li L, Stender H, Neziroglu N, Richter C, Kuhn H, Borchert A (2015) Expression of inactive glutathione peroxidase 4 leads to embryonic lethality, and inactivation of the Alox15 gene does not rescue such knock‐in mice. Antioxid Redox Signal 22: 281– 293 25313597
- Burk RF, Hill KE (2015) Regulation of selenium metabolism and transport. Annu Rev Nutr 35: 109– 134 25974694
- Burk RF, Hill KE, Motley AK, Austin LM, Norsworthy BK (2006) Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole‐body selenium content. Biochim Biophys Acta 1760: 1789– 1793 17014962 PMC1761947
- Carlisle AE, Lee N, Matthew‐Onabanjo AN, Spears ME, Park SJ, Youkana D, Doshi MB, Peppers A, Li R, Joseph AB et al (2020) Selenium detoxification is required for cancer‐cell survival. Nat Metab 2: 603– 611 32694795 PMC7455022
- Chen X, Yu C, Kang R, Kroemer G, Tang D (2021) Cellular degradation systems in ferroptosis. Cell Death Differ 28: 1135– 1148 33462411 PMC8027807
- Dharia NV, Kugener G, Guenther LM, Malone CF, Durbin AD, Hong AL, Howard TP, Bandopadhayay P, Wechsler CS, Fung I et al (2021) A first‐generation pediatric cancer dependency map. Nat Genet 53: 529– 538 33753930 PMC8049517
- Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron‐dependent form of nonapoptotic cell death. Cell 149: 1060– 1072 22632970 PMC3367386
- Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS et al (2014) Pharmacological inhibition of cystine‐glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3: e02523 24844246 PMC4054777
- Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Grocin AG, Xavier da Silva TN, Panzilius E, Scheel CH et al (2019) FSP1 is a glutathione‐independent ferroptosis suppressor. Nature 575: 693– 698 31634899
- Duan J, Hon GC (2021) FBA: feature barcoding analysis for single cell RNA‐Seq. Bioinformatics 37: 4266– 4268 33999185 PMC9502162
- Eaton JK, Ruberto RA, Kramm A, Viswanathan VS, Schreiber SL (2019) Diacylfuroxans are masked nitrile oxides that inhibit GPX4 covalently. J Am Chem Soc 141: 20407– 20415 31841309
- Floros KV, Cai J, Jacob S, Kurupi R, Fairchild CK, Shende M, Coon CM, Powell KM, Belvin BR, Hu B et al (2021) MYCN‐amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc−/glutathione axis. Cancer Res 81: 1896– 1908 33483374 PMC9281612
- Friedmann Angeli JP, Conrad M (2018) Selenium and GPX4, a vital symbiosis. Free Radic Biol Med 127: 153– 159 29522794
- Friedmann Angeli JP, Krysko DV, Conrad M (2019) Ferroptosis at the crossroads of cancer‐acquired drug resistance and immune evasion. Nat Rev Cancer 19: 405– 414 31101865
- Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X (2019) Role of mitochondria in ferroptosis. Mol Cell 73: 354– 363 30581146 PMC6338496
- Herold S, Kalb J, Buchel G, Ade CP, Baluapuri A, Xu J, Koster J, Solvie D, Carstensen A, Klotz C et al (2019) Recruitment of BRCA1 limits MYCN‐driven accumulation of stalled RNA polymerase. Nature 567: 545– 549 30894746 PMC7611299
- Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T et al (2018) Selenium utilization by GPX4 is required to prevent hydroperoxide‐induced ferroptosis. Cell 172: 409– 422 29290465
- Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F (2017) Genome‐scale CRISPR‐Cas9 knockout and transcriptional activation screening. Nat Protoc 12: 828– 863 28333914 PMC5526071
- Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Muller C, Zandkarimi F, Merl‐Pham J, Bao X, Anastasov N, Kossl J et al (2020) GTP Cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci 6: 41– 53 31989025 PMC6978838
- Lewerenz J, Ates G, Methner A, Conrad M, Maher P (2018) Oxytosis/ferroptosis‐(Re‐) emerging roles for oxidative stress‐dependent non‐apoptotic cell death in diseases of the central nervous system. Front Neurosci 12: 214 29731704 PMC5920049
- Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, Irizarry RA, Liu JS, Brown M, Liu XS (2014) MAGeCK enables robust identification of essential genes from genome‐scale CRISPR/Cas9 knockout screens. Genome Biol 15: 554 25476604 PMC4290824
- Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK et al (2022) CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40: 365– 378 35216678 PMC9007863
- Liu H, Schreiber SL, Stockwell BR (2018) Targeting dependency on the GPX4 lipid peroxide repair pathway for cancer therapy. Biochemistry 57: 2059– 2060 29584411 PMC5962875
- Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G et al (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25: 404– 414 36747082 PMC10027392
- Lu Y, Yang Q, Su Y, Ji Y, Li G, Yang X, Xu L, Lu Z, Dong J, Wu Y et al (2021) MYCN mediates TFRC‐dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death Dis 12: 511 34011924 PMC8134466
- Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B et al (2021) DHODH‐mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593: 586– 590 33981038 PMC8895686
- Olm E, Fernandes AP, Hebert C, Rundlof AK, Larsen EH, Danielsson O, Bjornstedt M (2009) Extracellular thiol‐assisted selenium uptake dependent on the x(c)‐ cystine transporter explains the cancer‐specific cytotoxicity of selenite. Proc Natl Acad Sci U S A 106: 11400– 11405 19549867 PMC2708693
- Olson GE, Winfrey VP, Nagdas SK, Hill KE, Burk RF (2007) Apolipoprotein E receptor‐2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J Biol Chem 282: 12290– 12297 17314095
- Shah R, Shchepinov MS, Pratt DA (2018) Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci 4: 387– 396 29632885 PMC5879472
- Solovyev N, Berthele A, Michalke B (2013) Selenium speciation in paired serum and cerebrospinal fluid samples. Anal Bioanal Chem 405: 1875– 1884 22868477
- Spahn PN, Bath T, Weiss RJ, Kim J, Esko JD, Lewis NE, Harismendy O (2017) PinAPL‐Py: a comprehensive web‐application for the analysis of CRISPR/Cas9 screens. Sci Rep 7: 15854 29158538 PMC5696473
- Superti‐Furga G, Lackner D, Wiedmer T, Ingles‐Prieto A, Barbosa B, Girardi E, Goldmann U, Gurtl B, Klavins K, Klimek C et al (2020) The RESOLUTE consortium: unlocking SLC transporters for drug discovery. Nat Rev Drug Discov 19: 429– 430 32265506
- Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta‐Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P et al (2019) STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome‐wide experimental datasets. Nucleic Acids Res 47: D607– D613 30476243 PMC6323986
- Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore‐Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ et al (2017) Dependency of a therapy‐resistant state of cancer cells on a lipid peroxidase pathway. Nature 547: 453– 457 28678785 PMC5667900
- Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156: 317– 331 24439385 PMC4076414
- Zhang W, Yu Y, Hertwig F, Thierry‐Mieg J, Zhang W, Thierry‐Mieg D, Wang J, Furlanello C, Devanarayan V, Cheng J et al (2015) Comparison of RNA‐seq and microarray‐based models for clinical endpoint prediction. Genome Biol 16: 133 26109056 PMC4506430
- Authors
- Alborzinia, H., Chen, Z., Yildiz, U., Freitas, F. P., Vogel, F. C. E., Varga, J. P., Batani, J., Bartenhagen, C., Schmitz, W., Büchel, G., Michalke, B., Zheng, J., Meierjohann, S., Girardi, E., Espinet, E., Flórez, A. F., dos Santos, A. F., Aroua, N., Cheytan, T., Haenlin, J., Schlicker, L., Xavier da Silva, T. N., Przybylla, A., Zeisberger, P., Superti‐Furga, G., Eilers, M., Conrad, M., Fabiano, M., Schweizer, U., Fischer, M., Schulze, A., Trumpp, A., & Friedmann Angeli, J. P.
- Affiliations
- German Cancer Research Center (DE)
- University of Würzburg (DE)
- European Molecular Biology Organization (DE)
- University of Cologne (DE)
- Universitätsklinikum Würzburg (DE)
- Helmholtz Munich (DE)
- Austrian Academy of Sciences (AT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Harvard University (US)
- University of Bonn (DE)
- Corresponding author
- Alborzinia, Hamed
- Trumpp, Andreas
- ORCID
- Alborzinia, Hamed
- Chen, Zhiyi
- Yildiz, Umut
- Freitas, Florencio Porto
- Vogel, Felix C E
- Varga, Julianna Patricia
- Bartenhagen, Christoph
- Schmitz, Werner
- Büchel, Gabriele
- Michalke, Bernhard
- Zheng, Jashuo
- Meierjohann, Svenja
- Girardi, Enrico
- Espinet, Elisa
- Flórez, Andrés F
- Aroua, Nesrine
- Cheytan, Tasneem
- Schlicker, Lisa
- Xavier da Silva, Thamara N
- Superti‐Furga, Giulio
- Eilers, Martin
- Conrad, Marcus
- Fabiano, Marietta
- Schweizer, Ulrich
- Fischer, Matthias
- Schulze, Almut
- Trumpp, Andreas
- Friedmann Angeli, José Pedro
- Venue
- EMBO Molecular Medicine
- Published
- 2023-07-12
- Volume
- 15
- Issue
- 8
- Pages
- e18014-e18014
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC10405063
- OpenAlex
- W4383999429
- Cited by
- 85
- References
- 48
- Citations by year
- 2026: 29 · 2025: 27 · 2024: 26 · 2023: 3
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EMBO Molecular Medicine (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Alexander von Humboldt‐Stiftung
- Austrian Academy of Science
- Bundesministerium für Bildung und Forschung (01ZX1603, 01ZX1607)
- Deutsche Forschungsgemeinschaft (FR 3746/3‐1, FR 3746/6‐1, INST 269/886‐1, FOR2674, 1926/2‐1, 6984/1‐1, SPP2306, SCHU 2670/4‐1, SCHU 2670/2‐2 (FOR2314), CO 297/9‐1, CO 291/7‐1, CO 291/10‐1, FOR2314, SFB1399, CC873)
- Deutsche Krebshilfe (70113450)
- Deutschen Konsortium für Translationale Krebsforschung
- Dietmar Hopp Stiftung
- EC | European Research Council (GA 884754, 695214)
- EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska‐Curie Actions (MSCA‐IF‐2014‐661491)
- Förderverein für Krebskranke Kinder
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Neurology › Neuroblastoma Research and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Selenium in Biological Systems
- Keywords
- LRP8, ferroptosis, MYCN-amplified neuroblastoma, selenoprotein P, GPX4, selenium metabolism, system xc-, CRISPR activation screen, orthotopic xenograft
- MeSH terms
- N-Myc Proto-Oncogene Protein, Ferroptosis, Animals, Humans, Neuroblastoma, Selenocysteine, LDL-Receptor Related Proteins, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review